Psylink is a deep-tech biotechnology company developing innovative, science-driven treatments for mental health disorders, with a focus on patients who do not respond to conventional therapies.
Psylink has raised €502k across 1 funding round from 4 investors, most recently a Pre-Seed round in Jul 2025. Based in Vilnius, Lithuania; active in Deeptech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-07-29 | Pre-Seed | €502k |
| BSV Ventures,Coinvest Capital,FIRSTPICK,syndicate of angel investors |
| View deal → |
